3 Undervalued Gems to Buy for Less Than $30

Undervalued stocks, such as Green Thumb Industries, have the potential to outpace the broader markets in 2023 and beyond.

| More on:
diamonds, hidden gems

Image source: Getty Images

Investing in undervalued stocks, or those trading below their intrinsic value, is a popular strategy on Wall Street. You need to identify companies that are flying under the radar and trading at attractive multiples, allowing you to derive outsized gains over time.

Wall Street stalwarts, including Warren Buffett and Benjamin Graham, have made this investment strategy popular, enabling them to build generational wealth in the long run. Here, I have identified three undervalued stocks trading at less than $30.

Green Thumb Industries

One of the largest pot producers globally, Green Thumb Industries (CNSX:GTII) is a multi-state operator valued at a market cap of $2.6 billion. A multi-state operator that enjoys consistent profits, Green Thumb stock is down over 60% from all-time highs. It has reported a positive net income for 10 consecutive quarters and is on track to surpass $1.5 billion in annual sales this year.

In the last three quarters, Green Thumb reported a net income of US$63 million, an increase of 20% compared to the year-ago period. Comparatively, its sales rose by 20% to US$758 million, indicating a net margin of 8.3%.

The cannabis giant is well poised to benefit if marijuana is legalized at the federal level in the U.S. due to its huge presence in several states south of the border.

Priced at less than two times forward sales and 19.5 times forward earnings, Green Thumb is attractively valued. Analysts tracking GTII stock remain bullish and expect it to gain close to 200% in the next 12 months.

Well Health Technologies

A high-growth company part of the rapidly expanding health-tech space, Well Health (TSX:WELL) should be part of your shopping list in 2023. Its omnichannel business model allows Well Health to generate predictable revenue. Moreover, Well Health should also benefit from the network effects driven by the acquisition of multiple healthcare assets in recent years.

The company’s patient services are delivered at scale and in partnership with its network of integrated care facilities. In fact, Well Health operates the largest outpatient medical clinic network in Canada.

Its virtual business includes services such as telehealth, revenue cycle management, digital booking, and workflow automation, among others.

Valued at a market cap of $892 million, WELL stock is priced at 1.4 times 2023 sales. Analysts expect the stock to almost double in the next year.

Dye & Durham

The final undervalued stock on my list is Dye & Durham (TSX:DND), an enterprise-facing company valued at $1.26 billion.

Armed with a customer base of over 60,000, Dye & Durham reported revenue of $120.2 million and adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) of $64.4 million in the fiscal first quarter of 2023 (ended in September). Global real estate transactions accounted for 68% of revenue, providing investors with regional diversification.

In terms of its balance sheet, DND has net debt of $676 million, while its EBITDA in the last 12 months stood at $269 million, indicating a debt-to-EBITDA multiple of 2.5 times.

Analysts expect sales to surge over $500 million in fiscal 2024. So, DND stock is priced at less than three times forward sales, which is quite attractive for value investors.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned. The Motley Fool recommends Green Thumb Industries. The Motley Fool has a disclosure policy.

More on Investing

Man holding magnifying glass over a document
Stocks for Beginners

TFSA Investors: Make Your Recession Watchlist Now!

These long-term stocks offer immense value for TFSA investors looking to create immense returns coming out of a recession.

Read more »

Profit dial turned up to maximum
Dividend Stocks

2 TSX Dividend Stocks With Seriously Huge Payouts

The TSX telecom sector has some great high-yielding companies up for grabs.

Read more »

TFSA and coins
Dividend Stocks

Dividend Stocks With Yields TFSA Investors Should Lock In Now!

Are you looking to build a passive-income stream? Here are two top dividend stocks to load up on in your…

Read more »

Gas pipelines
Energy Stocks

Better Energy Stock to Buy: Suncor or Canadian Natural Resources?

Suncor and Canadian Natural Resources are off their recent highs. Are these stocks now good to buy?

Read more »

tsx today
Stocks for Beginners

TSX Today: What to Watch for in Stocks on Thursday, March 23

TSX stocks may remain volatile, as investors continue to assess how the high interest rate environment could affect the economy…

Read more »

A plant grows from coins.
Dividend Stocks

2 Young TSX Stocks You’ll Be Glad You Bought in 10 Years

Youth means nothing when you plan to hold strong companies long term. These two TSX stocks should therefore be first…

Read more »

Man with no money. Businessman holding empty wallet
Dividend Stocks

Is it a Trap? 3 TSX Stocks With Ultra-High Dividend Yields 

Who doesn’t love dividends? But the high-interest rate environment makes ultra-high dividends unsustainable. Are these stocks a value trap?

Read more »

Value for money
Dividend Stocks

3 Value Stocks for Superior Returns in 2023

Given their solid underlying businesses, stable cash flows, high dividend yields, and attractive valuations, these three undervalued TSX stocks could…

Read more »